Medical Device Network on MSN

NAMSA acquires Labcorp’s medical device testing assets

The move adds Labcorp’s US biocompatibility, analytical testing, and preclinical research services to Namsa’s operations.
Business Wire

NAMSA Acquires the U.S. Medical Device Testing Operations of WuXi AppTec, Solidifying its Position as the Leader in MedTech Testing and Clinical Research

TOLEDO, Ohio--(BUSINESS WIRE)--NAMSA, a world-leading MedTech testing, clinical and regulatory consulting firm, announced today that it has entered into a definitive agreement to acquire the U.S.
usace.army.mil

MTEAC conducts operational testing of the multiple devices

JOINT BASE LEWIS-MCCHORD, WA–The U.S. Army Medical Test and Evaluation Activity (MTEAC), in collaboration with the U.S. Army Medical Materiel Development Activity (USAMMDA) Program Executive Office ...
MD&M East

Cytotoxicity Testing for Medical Devices: A Guide to Compliance & Best Practices

Medical device manufacturers use cytotoxicity testing to help prove that devices that come into contact with the human body are biocompatible. Testing results are critical for gaining market access, ...